Chongqing Genrix Biopharmaceutical Co (SHSE:688443) FCF Yield % : -4.34 (As of Jun. 25, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Chongqing Genrix Biopharmaceutical Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Chongqing Genrix Biopharmaceutical Co's Trailing 12-Month Free Cash Flow is ¥-483.62 Mil, and Market Cap is ¥11,132.41 Mil. Therefore, Chongqing Genrix Biopharmaceutical Co's FCF Yield % for today is -4.34%.

The historical rank and industry rank for Chongqing Genrix Biopharmaceutical Co's FCF Yield % or its related term are showing as below:

SHSE:688443' s FCF Yield % Range Over the Past 10 Years
Min: -4.99 Med: -3.81 Max: -3.13
Current: -4.34

During the past 5 years, the highest FCF Yield % of Chongqing Genrix Biopharmaceutical Co was -3.13%. The lowest was -4.99%. And the median was -3.81%.

SHSE:688443's FCF Yield % is ranked better than
73% of 1548 companies
in the Biotechnology industry
Industry Median: -14.645 vs SHSE:688443: -4.34

Chongqing Genrix Biopharmaceutical Co's FCF Margin % for the quarter that ended in Mar. 2024 was -2,528,333.33%.

Chongqing Genrix Biopharmaceutical Co FCF Yield % Historical Data

The historical data trend for Chongqing Genrix Biopharmaceutical Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Genrix Biopharmaceutical Co FCF Yield % Chart

Chongqing Genrix Biopharmaceutical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-3.20

Chongqing Genrix Biopharmaceutical Co Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial								-	-3.58	-4.15	-3.09	-4.11

Competitive Comparison of Chongqing Genrix Biopharmaceutical Co's FCF Yield %

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Genrix Biopharmaceutical Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's FCF Yield % falls into.

Chongqing Genrix Biopharmaceutical Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Chongqing Genrix Biopharmaceutical Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-468.56	/	14648.866
	=	-3.20%

Chongqing Genrix Biopharmaceutical Co's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-151.7	*	4	/	14766.2036
	=	-4.11%

Chongqing Genrix Biopharmaceutical Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Chongqing Genrix Biopharmaceutical Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Chongqing Genrix Biopharmaceutical Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chongqing Genrix Biopharmaceutical Co Ltd (SHSE:688443) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan, Chongqing, CHN, 401338

Website

http://www.genrixbio.com

Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.

Executives

Jiang Ren Sheng

Director

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Headlines

No Headlines